BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29220105)

  • 21. Supplemental selenium and coenzyme Q10 reduce glycation along with cardiovascular mortality in an elderly population with low selenium status - A four-year, prospective, randomised, double-blind placebo-controlled trial.
    Alehagen U; Aaseth J; Alexander J; Johansson P; Larsson A
    J Trace Elem Med Biol; 2020 May; 61():126541. PubMed ID: 32417634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selenium and Coenzyme Q
    Opstad TB; Alexander J; Aaseth JO; Larsson A; Seljeflot I; Alehagen U
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.
    Bogsrud MP; Langslet G; Ose L; Arnesen KE; Sm Stuen MC; Malt UF; Woldseth B; Retterstøl K
    Scand Cardiovasc J; 2013 Apr; 47(2):80-7. PubMed ID: 23301875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selenium and coenzyme Q10 interrelationship in cardiovascular diseases--A clinician's point of view.
    Alehagen U; Aaseth J
    J Trace Elem Med Biol; 2015; 31():157-62. PubMed ID: 25511910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
    Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Khodadadi B; Jazayeri S; Gohari MR; Aryaeian N
    Nutr Neurosci; 2015 May; 18(4):169-76. PubMed ID: 24621064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
    Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
    Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supplementation with selenium and coenzyme Q10 in critically ill patients.
    Hargreaves IP; Mantle D
    Br J Hosp Med (Lond); 2019 Oct; 80(10):589-593. PubMed ID: 31589506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial.
    Liu HT; Huang YC; Cheng SB; Huang YT; Lin PT
    Nutr J; 2016 Oct; 15(1):85. PubMed ID: 27716246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of selenium and Q10 on the cardiac biomarker NT-proBNP.
    Johansson P; Dahlström Ö; Dahlström U; Alehagen U
    Scand Cardiovasc J; 2013 Oct; 47(5):281-8. PubMed ID: 23895165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel biomarkers in human terminal heart failure and under mechanical circulatory support.
    Kramer F; Milting H
    Biomarkers; 2011 Jul; 16 Suppl 1():S31-41. PubMed ID: 21707442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.
    Lee BJ; Huang YC; Chen SJ; Lin PT
    Nutrition; 2012 Mar; 28(3):250-5. PubMed ID: 21996047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease.
    Lee BJ; Huang YC; Chen SJ; Lin PT
    Nutrition; 2012 Jul; 28(7-8):767-72. PubMed ID: 22342390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved Health-Related Quality of Life, and More Days out of Hospital with Supplementation with Selenium and Coenzyme Q10 Combined. Results from a Double Blind, Placebo-Controlled Prospective Study.
    Johansson P; Dahlström Ö; Dahlström U; Alehagen U
    J Nutr Health Aging; 2015 Nov; 19(9):870-7. PubMed ID: 26482687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coenzyme Q(10) and selenium in statin-associated myopathy treatment.
    Fedacko J; Pella D; Fedackova P; Hänninen O; Tuomainen P; Jarcuska P; Lopuchovsky T; Jedlickova L; Merkovska L; Littarru GP
    Can J Physiol Pharmacol; 2013 Feb; 91(2):165-70. PubMed ID: 23458201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
    J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of biomarkers in patients with chronic heart failure and healthy controls.
    Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
    Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects.
    Zaki ME; El-Bassyouni HT; Tosson AM; Youness E; Hussein J
    J Pediatr (Rio J); 2017; 93(1):100-104. PubMed ID: 27770619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men.
    Gökbel H; Gergerlioğlu HS; Okudan N; Gül I; Büyükbaş S; Belviranli M
    J Med Food; 2010 Feb; 13(1):216-8. PubMed ID: 20136458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
    Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.